An Evaluation of Prostate-Specific Antigen as a Screening Test for Prostate Cancer

1993 ◽  
Vol 153 (22) ◽  
pp. 2529 ◽  
Author(s):  
Victoria J. Dorr
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Screening Test ◽  
Specific Antigen

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1991 ◽  
Vol 324 (17) ◽  
pp. 1156-1161 ◽  
Author(s):  
William J. Catalona ◽  
Deborah S. Smith ◽  
Timothy L. Ratliff ◽  
Kathy M. Dodds ◽  
Douglas E. Coplen ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Screening Test ◽  
Specific Antigen

PROSTATE-SPECIFIC ANTIGEN AS A SCREENING TEST FOR PROSTATE CANCER

1997 ◽  
Vol 24 (2) ◽  
pp. 299-306 ◽  
Author(s):  
Carlos G. Arcangeli ◽  
David K. Ornstein ◽  
David W. Keetch ◽  
Gerald L. Andriole
Keyword(s):  
Prostate Cancer ◽  
Prostate Specific Antigen ◽  
Screening Test ◽  
Specific Antigen

scholarly journals Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer

BMJ ◽  
1995 ◽  
Vol 311 (7016) ◽  
pp. 1340-1343 ◽  
Author(s):  
C. Parkes ◽  
N. J Wald ◽  
P. Murphy ◽  
L. George ◽  
H. C Watt ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Observational Study ◽  
Prostate Specific Antigen ◽  
Screening Test ◽  
Prospective Observational Study ◽  
Specific Antigen

Unusually High PSA Level Allows Diagnosis of a Metastatic Prostate Cancer in Older Man

2020 ◽  
pp. 1-2
Author(s):  
Marion Pépin ◽  
M. Clua ◽  
J. Idoux ◽  
S. Ngo ◽  
T. Cudennec ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Ct Scan ◽  
Prostate Specific Antigen ◽  
Hormonal Therapy ◽  
Screening Test ◽  
Metastatic Prostate Cancer ◽  
Screening Program ◽  
Specific Antigen ◽  
Pelvic Ct Scan

Prostate cancer is now the most commonly diagnosed cancer amongst men in France despite the absence of a generalized screening program. Prostate-specific antigen (PSA) level can be used as a screening test. We report the case of an 86-year-old patient, whose metastatic prostate cancer was diagnosed on an unusually high PSA level (over 5000µg/L), without urologic signs. The diagnostic was then confirmed by a thoracicabdominal-pelvic CT scan, which found diffuse metastases, before hormonal therapy started.

Sign in / Sign up

Export Citation Format

Share Document